Zoetis reported $2.09B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
Align Technology ALGN:US $ 1696.58M 302.74M
Bayer BAYN:GR € 27926M 1006M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Charles River Laboratories CRL:US $ 929.61M 126.23M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Dentsply International XRAY:US 1.25B 39M
Eli Lilly And LLY:US $ 15093.2M 3379M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Henry Schein HSIC:US $ 2093.64M 29.13M
Horizon Pharma HZNP:US $ 852.81M 78.97M
Idexx Laboratories IDXX:US $ 651.81M 31.15M
Illumina ILMN:US $ 874M 394M
IQVIA Holdings Inc IQV:US $ 4.82B 49M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Kindred Biosciences KIN:US $ 11.26M 4.71M
Laboratory Of America LH:US $ 2667.1M 701.6M
Lannett LCI:US $ 90.47M 6.66M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Patterson Companies PDCO:US $ 1067.88M 21.78M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Phibro Animal Health PAHC:US $ 164.12M 4.78M
Quest Diagnostics DGX:US $ 1551M 156M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
Zoetis ZTS:US $ 2091M 25M